Changes in the NF–κB pathway and the AD‐related pathway (Figure S2D) were found in both groups, demonstrating that LPS + Aβ drug stimulation of BV2 cells is a reliable model of AD inflammation. Here, NFKB1 is linked to Alzheimer disease.